使用简便、易得的3-(4-甲氧基苯甲酰亚甲基)羟吲哚和3-(4-氟苯基氨基)-2-环己烯-1-酮为原料,在乙醇钠和乙醇的共同作用下,一步合成得到5-(4-氟苯基)-11-(4-甲氧基苯基)-1H-吲哚[2,3-b]喹啉-1-酮化合物。通过单晶X衍射法确定其结构,晶体属单斜晶系,空间群Cc,分子量Mr=537.57(包含1 分子溶剂DMF),晶胞参数a=1.44352(3) nm,b=2.6027(3) nm,c=0.93423(8) nm,V=2.6917(4) nm3,Z=4,晶胞密度Dc=1.327 Mg/m3,吸收系数μ=0.093 mm-1,单胞中电子的数目F(000)=1128。晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0631,Rω=0.1535。在晶体结构中新形成的含氮六元杂环近似于平面结构。
The title compound of 5-(4-fluorophenyl)-11-(4-methoxy benoyl)-2,3,4,5-tetrahydro-1H-indolo[2,3-b]quinolin-1-one has been synthesized by the reaction of simple and off-the-shalf 3-p-methoxyphenacylideneoxindole with 3-(4-fluorophenylamino) cyclohex-2-enone as raw material in the presence of EtONa in ethanol. The structure of title product is determined by single crystal X-ray diffraction. The crystal is monoclinic, space group Cc, with Mr=537.57 (containing a molecular DMF solvent), a=1.44352(3) nm, b=2.6027(3) nm, c=0.93423(8) nm, V=2.6917(4) nm3, Z=4, Dc=1.327 Mg/m3, μ=0.093 mm-1, F(000)=1128. The structure is solved by direct methods and refined by full-matrix least squares method to the final R=0.0631, Rω=0.1535. X-ray analysis reveals that the formation of the new nitrogen-bearing six-member heterocyclic ring in the crystal structure is a coplanar structure.
[1] Tu S J, Jiang B, Jia R H, et al. An efficient one-pot, three-component synthesis of indeno[1,2-b]quinolin-9,11(6H,10H)-dione, acridine-1,8 (2H,5H)-dione and quinoline-3-carboni trile derivatives from enaminones [J]. Organic & Biomolecular Chemistry, 2006, 4(19): 3664-3668.
[2] Zhu X T, Xu H W, Jiang B, et al. Efficient [4 + 1]/[3 + 2 + 1] biscyclizations stereoselectively yielding unprecedented polyacyclic indeno-fused xanthenes[J]. Tetrahedron Letters, 2013, 54(47): 6341-6344.
[3] Wright C W, Phillipson J D, Awe S O, et al. Antimalarial Activity of Cryptolepine and Some Other Anhydronium Bases[J]. Phytotherapy Research, 1996, 10(4): 361-363.
[4] Oyekan A O, Ablordeppey S Y. Effects of cryptolepine on collageninduced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets[J]. General Pharmacology: The Vascular System, 1993, 24(5): 1285-1290.
[5] Kirby G C, Paine A, Warhurst D C, et al. In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoloquinoline[J]. Phytotherapy Research, 1995, 9(5): 359-363.
[6] Zhu H J, Gooderham N J. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells[J]. Toxicological Sciences, 2006, 91(1): 132-139.
[7] Olajide O A, Heiss E H, Schachner D, et al. Synthetic cryptolepine inhibits DNA binding of NF-κB[J]. Bioorganic & Medicinal Chemistry, 2007, 15(1): 43-49.
[8] Chen Y L, Chung C H, Chen P H, et al. Synthesis and cytotoxic activity evaluation of indolo-, pyrrolo-, and benzofuro-quinolin-2(1H)-ones and 6-anilinoindoloquinoline derivatives[J]. Bioorganic & Medicinal Chemistry, 2002, 10(8): 2705-2712.
[9] Sundaram G S M, Venkatesh C, Syam Kumar U K, et al. A concise formal synthesis of alkaloid cryptotackiene and substituted 6H-indolo[2, 3-b]quinolines[J]. The Journal of Organic Chemistry, 2004, 69(17): 5760-5762.
[10] Sayed I E, Ramzy F, William S, et al. Neocryptolepine analogues containing N-substituted side-chains at C-11: Synthesis and antischistoso micidal activity[J]. Medicinal Chemistry Research, 2012, 21(12): 4219-4229.
[11] Tietze L F, Modi A. Multicomponent domino reactions for the synthesis of biologically active natural products and drugs[J]. Medicinal Research Reviews, 2000, 20(4): 304-322.
[12] Tietze L F, Rackelmann N. Domino reactions in the synthesis of heterocyclic natural products and analogs[J]. Pure and Applied Chemistry, 2004, 76(11): 1967-1983.
[13] PadwaA.Dominoreactionsofrhodium(II)carbenoidsforalkaloid synthesis [J]. Chemical Society Reviews, 2009, 38(11): 3072-3081.
[14] Aaron M D, Eric F. Meldrum's acids and 5-alkylidene meldrum's acids in catalytic carbon-carbon bond-forming processes[J]. Accounts of Chemical Research, 2010, 43(3): 440-454.
[15] Nazef N, Davies R D M, Greaney M F. Formal synthesis of merrilactone a using a domino cyanide 1,4-addition-aldol cyclization[J]. Organic Letters, 2012, 14(14): 3720-3723.
